Form 4: VolitionRx Director Innes Receives Stock Award in Lieu of Cash Compensation
SEC Form 4 Filing
Director Guy Archibald Innes of VolitionRx Ltd. received 17,296 restricted stock units in lieu of cash compensation, according to a recent SEC filing.
Summary
- Guy Archibald Innes, a director at VolitionRx Ltd., was granted 17,296 restricted stock units (RSUs) on December 1, 2024.
- These RSUs were awarded in place of cash compensation that would have otherwise been paid to Mr. Innes.
- The RSUs vest in multiple installments: three equal portions of 5,766, 5,765, and 5,765 units on December 1, 2024, January 1, 2025, and February 1, 2025, respectively, with a final vesting on July 1, 2025.
- The vesting is contingent upon continued service through each vesting date.
- Upon vesting, Mr. Innes will receive common stock equal to the number of vested RSUs.
- Mr. Innes also has indirect beneficial ownership of 1,400,000 shares through The Innes Family Bare Trust 2023, 356,000 shares through The Dill Faulkes Educational Trust Limited, and 154,503 shares each through two sons and 154,504 shares each through two daughters.
Sentiment
Score: 7
Explanation: The document reflects a standard compensation practice, which is generally neutral to positive. The vesting schedule is a positive sign of alignment with shareholders.
Positives
- The award of RSUs aligns the director's interests with those of the shareholders.
- The vesting schedule encourages continued service from the director.
Risks
- The value of the RSUs is subject to the volatility of the company's stock price.
- The director's continued service is required for the RSUs to fully vest.
Future Outlook
The director will receive shares of common stock upon the vesting of the RSUs, subject to continued service.
Industry Context
The granting of stock-based compensation to directors is a common practice in publicly traded companies to align their interests with those of shareholders.
Comparison to Industry Standards
- Stock-based compensation is a standard practice for directors in publicly traded companies, often used to incentivize performance and align interests with shareholders.
- The vesting schedule of the RSUs is typical, with staggered vesting dates to encourage continued service.
- Many companies use a combination of cash and stock-based compensation for directors, and this case is a substitution of cash for stock.
Stakeholder Impact
- Shareholders may view the stock award as a positive sign of alignment between management and shareholder interests.
- The director is incentivized to continue service with the company.
Key Dates
| Date | Description |
|---|---|
| 12/01/2024 | Date of the RSU award and first vesting installment. |
| 01/01/2025 | Second vesting installment date for the RSUs. |
| 02/01/2025 | Third vesting installment date for the RSUs. |
| 07/01/2025 | Final vesting date for the RSUs. |
| 12/03/2024 | Date of the SEC filing. |
Keywords
restricted stock units, RSUs, stock award, director compensation, beneficial ownership, insider trading, VolitionRx, VNRX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.